§01 Browse › MK-677

MK-677

Ibutamoren MK677 Nutrobal
Non-suppressive

None

Technical catalog description

MK-677 (Ibutamoren) is an orally active growth hormone secretagogue that mimics ghrelin at the GHSR receptor. It is not a peptide. It is a small-molecule oral compound that raises GH and IGF-1 indirectly by pushing the ghrelin pathway.

That makes it a good fit for the metabolic/modulator bucket rather than the peptide bucket. In practice users choose it for sleep quality, appetite, recovery, and the long-horizon GH-axis support story without injections.

Overview Use context Comparison Safety
Warning
Dramatically increases appetite and can make cutting miserable · May worsen fasting glucose and insulin sensitivity over time · Water retention and lethargy are common at sloppy doses

Read next

GLP-1 Drugs: Semaglutide, Tirzepatide, and Retatrutide 5 min readThe Growth Hormone, IGF-1, and Recovery Axis 9 min readAdvanced Labs Interpretation 12 min read
More depthCutting Compounds Beyond GLP-1sThyroid Hormones and Fat LossInsulin Sensitivity, Glucose Disposal, and Anabolism
Overview
Mechanism details

MK-677 (ibutamoren) is a non-peptide GH secretagogue, an orally active compound that binds the ghrelin receptor (GHSR) and stimulates pulsatile growth hormone release from the pituitary. Unlike direct hGH injection, it relies on pituitary GH reserve to amplify. Its oral route does not establish an administration frequency.

Because it binds the ghrelin receptor, it carries ghrelin-like effects: pronounced appetite stimulation, increased sleep quality, and mild water retention. The appetite increase is significant, and that alone is enough to make it a poor fit for aggressive cuts even when users like the sleep benefit.

Safety & monitoring
Side effects

  • Water retention, sharp appetite increase, lethargy, and reduced insulin sensitivity

  • Numb hands and higher fasting glucose in susceptible users

Monitoring

  • fasting glucose / HbA1c

  • bodyweight

  • blood pressure

Avoid if

  • Pre-diabetes, uncontrolled appetite, or edema-prone users with weak monitoring habits

  • Treating it like a harmless sleep aid or GH replacement

Use context

MK-677 is chosen by users who want some of the GH-axis story without injections: better sleep, recovery, skin quality, and a slow body-composition push over time. The oral convenience is the main reason it survives.

Common mistakes

Starting too high. Running it for months without checking glucose. Calling it a peptide because it lives in the GH-secretagogue conversation when pharmacologically it is a small-molecule oral modulator.

Comparison notes

Compared with hGH, MK-677 is cheaper and easier but less precise. Compared with injectable peptides (Ipamorelin, GHRP-2), it removes injections but also removes the more controllable pulse-style scheduling.

Record quantities in the builder Read: GLP-1 Drugs: Semaglutide, Tirzepatide, and Retatrutide ← Browse